![STOCKTALK CENTRAL SPECIAL ALERT]() |
| NEWS ALERT! |
| IBXG Group, Inc. (OTCBB: IBXG) |
Near Term Price Projection: $.38 |
|
| SHARES OUTSTANDING: |
50 million |
| APPROX. FLOAT: |
20 million |
| Near Term Price Proj.: |
$.38 |
|
| A Few Reasons To Own IBXG |
|
- IBXG is an emerging growth company in the trillion-dollar healthcare industry.
- IBXG is coming off its fourth quarter in a row of increasing revenues and its second consecutive profitable quarter. IBXG experienced a 50% gain in third quarter revenue.
- IBXG estimated EPS for all of 2002 is estimated to be $.01 per share.
- IBXG is currently cash flow positive. IBXG is making acquisitions and expanding its infrastructure while vigorously pursuing the Marketing Plan.
- IBXG is a results-oriented company with three integrated divisions - Healthcare Transaction Services, Physical Therapy & Occupational Medicine, and Technology/Information Services.
- IBXG has established a strong market niche in the area of Healthcare Transaction Services.
- IBXG recently began managing its largest receivables management project ever totaling $39 million from Intracoastal Health Systems, Inc. of West Palm Beach, Florida.
- IBXG has implemented a clear-cut strategic plan to expand its capabilities in the area of Physical Therapy and Occupational Medicine.
- IBXG has developed and recently commenced marketing an innovative web-based inventory management application for the $1.5 billion durable medical equipment (DME) industry.
- IBXG has developed and deployed a proprietary online consumer medical records service throughout the U.S. The technology is being utilized by several affinity groups, including one of the largest credit card companies in the world.
- IBXG's internal compliance program has been certified as meeting all current requirements of the Federal Health Insurance Portability and Accountability Act (HIPAA).
|
|
|
Great News! Well the IBXG PR Machine Continues To Roll And Now With A Contract Extension.
One Of The Most Important Sales In any Business is Repeat Business Or Another Words Contract Extensions.
Generally It Means That The Company (IBXG) Has Lived Up to Its Expectations. That Its Customer Is Satisfied With The Product and Services Provided and Both Parties Want to Continue Their Working Relationship.
We Think There Is No Better Testimonial Than A Contract Extension.
In Our Opinion, This Should Help IBXG Gain Additional Business and Revenue From Potential Prospects Who Have Expressed Interest In Its Capabilities and Were Waiting For Results.
As Quoted From Today's PR:
"hospital systems across the country have expressed interest in NursesSTAT's technological capabilities and are eagerly anticipating the results of the company's partnership with the hospitals. The revenue projections for the division for 2004 have been revised to reflect the contract extension to over $ 5 million."
In Our Last Few Profiles We Spoke About IBXG Having Some Of The KEY INGREDIENT's TO THE SUCCESS FOR ANY BUSINESS, One Being Management and The Other Timing,
Now Add Satisfied Customers, and It Seems To Us That IBXG IS A Stock To Watch Over The Near Term.
WE STILL CONTINUE TO MAKE THIS ARGUMENT:
According to a March 17th, 2003 PR from IBXG whereby IBXG raised revenue guidance for this year from $11 Million Dollars to $14 Million Dollars, and since then has announced Additional Revenue Deals such as today's PR, there has been virtually NO CHANGE IN IBXG's STOCK PRICE.
If we now compare IBXG to its peers, the peer group trades in the marketplace (according to Multex) at 27 times earnings and about 6 times sales, then applying these multiples to IBXG on an EPS basis IBXG should be worth TODAY $.47 Per Share, and on a multiple of sales IBXG should be worth TODAY almost $1.45 Per Share.
IBXG's Market Cap is about $6 Million Dollars with estimating $14 Million Dollars Plus in Revenues for 2003, and expecting to Earn over $1 Million Dollars.
IN OUR OPINION, AT CURRENT STOCK PRICE LEVELS IBXG IS GROSSLY UNDERVALUED, AND WE BELIEVE IS DO FOR A POP TO HIGHER STOCK MARKET VALUATION'S AND HOPEFULLY SOON.
So keep a Real, Real Close Eye on IBXG as we think MORE PR IS LIKELY FORTHCOMING, and as always,
Watch This Stock Trade.
|
|
NURSESSTAT® EXTENDS STAFFING TECHNOLOGY APPLICATION CONTRACT INTO 2004 WITH PROMINENT FLORIDA HOSPITALS DEERFIELD BEACH, Fla., Sept 22, 2003 - NursesSTAT®, a leading-edge provider of healthcare staffing solutions and employee leasing services, announced today that it has extended its current contract through May 2004 on its innovative Web-enabled staffing application at four large South Florida hospitals. NursesSTAT, a division of Florida-based iBX Group, Inc. (OTC Bulletin Board: IBXG), has been servicing an agreement to provide a staffing application designed for the management of nurses and ancillary personnel for these facilities.
Brian Virgo, Managing Director for NursesSTAT, said hospital systems across the country have expressed interest in NursesSTAT's technological capabilities and are eagerly anticipating the results of the company's partnership with the hospitals. To reflect the contract extension, revenue projections for NursesSTAT have been revised to over $5 million for 2004. The revenue structure of the company is based on a monthly service fees, as well as bonuses for savings and cost containment.
"Our vision is to evolve NursesSTAT into a total healthcare staffing solution," Virgo said. "We hope to ease the severe medical staffing shortage affecting healthcare organizations nationwide by connecting qualified personnel with understaffed facilities. We also have established a financial services division that will provide other staffing companies with the capital to take on additional personnel and offer better working conditions for existing staff."
The system deployment, conducted simultaneously at the four facilities, has been extremely productive, according to Virgo. "We successfully deployed our patented technology to approximately 100 nurses, and about 500 more nurses are scheduled for training in the coming weeks," Virgo said. "We will also be introducing a multimedia training program that nurses will be able to access over the Internet."
Due to a nationwide shortage of nurses, as well as increasing turnover rates, hospitals are being forced to rely on staffing agencies to fill vacancies. In 2000, per diem nurse staffing represented an estimated $4.1 billion in revenues and was the largest sector of the temporary medical staffing industry. Virgo said his company is focused on helping hospitals better utilize their internal resources and avoid paying expensive staffing agencies salaries.
NursesSTAT provides a patented, Web-enabled application to maintain a national network of qualified nurses and other healthcare professionals, while deploying wireless technology to make those individuals available to healthcare facilities 24 hours a day, seven days a week.
Participating facilities begin by creating a customized staffing application. Using the Internet, a nurse joins the facility's "super pool" by entering his or her name, contact information, and key staffing information, such as license, shift availability, specialized nursing experience and financial requirements.
Based in Deerfield Beach, Florida, iBX Group Inc. develops and deploys creative, cost-effective methods for integrating financial, administrative and information services for the healthcare industry. iBX is a results-oriented company, consisting of five divisions - iBX Technologies, which enables healthcare organizations to maximize their accounts receivables; Florida HealthSource, a network of physical therapy and wellness centers; MediCompliant Solutions, which ensures medical practices' compliance with today's complex legal requirements; iBX Transcription Services, which offers physicians quick turn-around and Web-accessible progress reports; NursesSTAT, a revolutionary temporary staffing solution; SportshealthNet.com and TheNetDigest.com, interactive Web portals providing patients with comprehensive healthcare information and advice, and increasing physician referrals.
This release is comprised of interrelated information that must be interpreted in the context of all of the information provided and care should be exercised not to consider portions of this release out of context. This release contains certain "forward-looking statements and information" (as defined in the Private Securities Litigation Reform Act of 1995) concerning iBX Group, Inc. that are based on the beliefs of iBX Group, Inc.'s management, as well as assumptions made by and information currently available to iBX Group, Inc. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in iBX's filings with the Securities and Exchange Commission.
|
|
|
A Penny Stock with Multi-Dollar Potential: Trading Today in the Teens, but in our opinion, has Near-Term Potential for Huge Gains. IBXG may be one This Year's BIG surprises, making its current status as an undiscovered stock a rare timing opportunity for investors. Don't overlook this one! We not only consider IBXG an attractive "Emerging Growth Company," in our opinion, but also a "Value Stock" in view of its Revenues and Earnings. We believe that IBXG has targeted a creative niche in a hot sector.
Relative to comparative companies within the Healthcare Sector, IBXG could realize superior growth in business and earnings over the Near- Term period. A grouping of comparable companies within this Sector currently trades at an average price to revenues multiple of 6.19 X. For 2003 it is now estimated that IBXG should generate revenues of about $15 MILLION DOLLARS, and EPS of $0.02 Per Share.
If over the Near-Term IBXG were to trade in the Market Place at a 80% Discount to its Peers, then applying the comparative grouping's price to revenue multiples to IBXG we can arrive at a relative valuation of $.38 per share over the Near-Term.
|
|
|
"Patients want to do more of their medical management from home, doctors want to provide care quickly and efficiently, and hospitals and HMO’s want to keep costs down," says Jim Gabler, a research director for GartnerGroup’s Healthcare Industry Research and Advisory Services in Stamford, Conn. "All of this relates to technology, and it’s up to CIO’s to find a better way. People say healthcare revolves around doctors and patient care. Well in the months and years to come, the industry will revolve around technology and the CIO."
Given this climate in healthcare today, in our opinion, IBXG is an undervalued opportunity. IBXG is perfectly positioned to meet the needs of their target market with a strong commitment to their suite of services.
Aggressive investors looking for above-average return potential on a portion of their investment capital should give IBXG a serious look.
|
|
|
Are you a CEO of a Public Company or the Head of an Investor Relations or Public Relations Firm interested in Advertising your Company, or do you have a Product or Service that you would like Advertised to what we believe is the most Qualified & Largest Permission Based Opt-in Membership in the World, demographically speaking.
Unlike any other Email Marketer in the World, we can Guarantee Your Advertisement to be Opened and Read by over 1 Million of our Membership within 12 Hours of when we start to send Emails. We believe no other Email Marketer in the World can make this claim.
Yes, that’s right Guaranteed and Verified by what we believe is the Most Sophisticated Tracking Software in the World. Don’t be confused with other offers to Send Million’s of Emails as opposed to our offer whereby over 1 Million of our Members actually Open and Read Your Advertisement within 12 Hours of when we start to send emails, and many more thereafter.
We Don’t Come Cheap! We charge a premium for our services. So, only serious inquiries need to reply. If you are interested in learning more about our services, please click here and provide us with your contact information and some detail of what you are looking to advertise. If we are interested one of our representative’s will contact you shortly.
|
Disclaimer:
The purpose of this advertisement is to provide publicity for the advertised company, its products or services. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. StockTalk Central, and affiliates (STC), publishes reports providing information on selected companies that STC believes has investment potential. STC is not a registered investment advisor or broker-dealer. The above report is the opinion of STC and is not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. STC accepts no liability for any loss arising from an investor's reliance on or use of this report. An investment in IBXG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Previously, an affiliate of STC has been compensated one hundred forty-five thousand dollars by the company, and additionally received 7.2 million warrants exercisable into free trading shares of common stock of IBXG at ten cents per share and an additional 1 million warrants exercisable into free trading shares of common stock of IBXG at thirteen cents per share and an additional 2 million warrants exercisable into free trading shares of common stock of IBXG at five cents per share by a third party for the publication and circulation of previous reports, of which all the warrants have been exercised and the stock sold. In addition, IBXG has extended their agreement for the publication and circulation of this report, and an affiliate of STC has been compensated one hundred thousand dollars and received an additional 2 million warrants exercisable into free trading shares of IBXG at ten cents per share by a third party non-affiliate (TFST) and STC and affiliates have no relationship whatsoever to the third party. STC intends to sell all or a portion of the IBXG stock at or about the time of publication of this report. Subsequently STC may buy or sell shares of IBXG stock in the open market. Since an affiliate of STC has been compensated there is an inherent conflict of interest. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. For further details concerning these risks and uncertainties, see the SEC filings of IBXG including the company's most recent annual and quarterly reports.
|
|
|
